JP2011520877A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011520877A5 JP2011520877A5 JP2011509442A JP2011509442A JP2011520877A5 JP 2011520877 A5 JP2011520877 A5 JP 2011520877A5 JP 2011509442 A JP2011509442 A JP 2011509442A JP 2011509442 A JP2011509442 A JP 2011509442A JP 2011520877 A5 JP2011520877 A5 JP 2011520877A5
- Authority
- JP
- Japan
- Prior art keywords
- ethyl
- active ingredient
- cycloheptanecarbonyloxy
- azonia
- bicyclo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0808710A GB0808710D0 (en) | 2008-05-13 | 2008-05-13 | New combination 296 |
| GB0808710.8 | 2008-05-13 | ||
| GB0900563A GB0900563D0 (en) | 2009-01-14 | 2009-01-14 | New combination |
| GB0900563.8 | 2009-01-14 | ||
| PCT/SE2009/050525 WO2009139708A1 (en) | 2008-05-13 | 2009-05-12 | PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A β2-ADRENOCEPTOR AGONIST |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011520877A JP2011520877A (ja) | 2011-07-21 |
| JP2011520877A5 true JP2011520877A5 (https=) | 2012-06-07 |
Family
ID=41318921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011509442A Pending JP2011520877A (ja) | 2008-05-13 | 2009-05-12 | ムスカリン受容体アンタゴニストおよびβ２−アドレナリン受容体アゴニストを含む医薬品 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20110190309A1 (https=) |
| EP (1) | EP2315589A4 (https=) |
| JP (1) | JP2011520877A (https=) |
| KR (1) | KR20110010725A (https=) |
| CN (2) | CN102088976B (https=) |
| AU (1) | AU2009247021B2 (https=) |
| BR (1) | BRPI0912657A2 (https=) |
| CA (1) | CA2723909A1 (https=) |
| MX (1) | MX2010012019A (https=) |
| RU (1) | RU2010147881A (https=) |
| WO (1) | WO2009139708A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200825084A (en) * | 2006-11-14 | 2008-06-16 | Astrazeneca Ab | New compounds 521 |
| EA017627B1 (ru) | 2008-05-13 | 2013-01-30 | Астразенека Аб | Хинуклидиновые производные в качестве антагонистов мускаринового м3 рецептора |
| GB201016912D0 (en) | 2010-10-07 | 2010-11-24 | Astrazeneca Ab | Novel combination |
| KR101845257B1 (ko) | 2011-02-07 | 2018-04-04 | 삼성전자주식회사 | 이미지 센서 |
| JP2011195593A (ja) * | 2011-06-30 | 2011-10-06 | Astrazeneca Ab | ムスカリンｍ３受容体アンタゴニストとしてのキヌクリジン誘導体 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL62140C (https=) * | 1942-12-16 | |||
| GB8334494D0 (en) * | 1983-12-24 | 1984-02-01 | Tanabe Seiyaku Co | Carbostyril derivatives |
| GR1001529B (el) * | 1990-09-07 | 1994-03-31 | Elmuquimica Farm Sl | Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης. |
| US6223485B1 (en) * | 1996-06-07 | 2001-05-01 | Herman Miller, Inc. | Wall panel system |
| SK4699A3 (en) * | 1996-07-29 | 2000-04-10 | Pharmacia & Upjohn Ab | Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation |
| US6613795B2 (en) * | 1996-11-11 | 2003-09-02 | Christian Noe | Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments |
| JP2004532874A (ja) * | 2001-04-03 | 2004-10-28 | アリックス セラピューティクス | 抗コリン作用性化合物および使用法 |
| US7056916B2 (en) * | 2002-11-15 | 2006-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
| AR044134A1 (es) * | 2003-05-02 | 2005-08-24 | Novartis Ag | Derivados de quinuclidina, metodo de preparacion y composiciones farmaceuticas. |
| GB0424284D0 (en) * | 2004-11-02 | 2004-12-01 | Novartis Ag | Organic compounds |
| TW200738658A (en) * | 2005-08-09 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
| TW200738659A (en) * | 2005-08-29 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
| WO2008059239A1 (en) * | 2006-11-14 | 2008-05-22 | Astrazeneca Ab | Novel compounds 514 |
| TW200825084A (en) * | 2006-11-14 | 2008-06-16 | Astrazeneca Ab | New compounds 521 |
| TW200833670A (en) * | 2006-12-20 | 2008-08-16 | Astrazeneca Ab | Novel compounds 569 |
| GB0702456D0 (en) * | 2007-02-08 | 2007-03-21 | Astrazeneca Ab | New combination |
| GB0702457D0 (en) * | 2007-02-08 | 2007-03-21 | Astrazeneca Ab | New combination 666 |
| GB0704000D0 (en) * | 2007-03-01 | 2007-04-11 | Astrazeneca Ab | Salts 670 |
| EA017627B1 (ru) * | 2008-05-13 | 2013-01-30 | Астразенека Аб | Хинуклидиновые производные в качестве антагонистов мускаринового м3 рецептора |
| JP2011195593A (ja) * | 2011-06-30 | 2011-10-06 | Astrazeneca Ab | ムスカリンｍ３受容体アンタゴニストとしてのキヌクリジン誘導体 |
-
2009
- 2009-05-12 CN CN200980127403XA patent/CN102088976B/zh not_active Expired - Fee Related
- 2009-05-12 JP JP2011509442A patent/JP2011520877A/ja active Pending
- 2009-05-12 BR BRPI0912657A patent/BRPI0912657A2/pt not_active IP Right Cessation
- 2009-05-12 KR KR1020107025392A patent/KR20110010725A/ko not_active Withdrawn
- 2009-05-12 WO PCT/SE2009/050525 patent/WO2009139708A1/en not_active Ceased
- 2009-05-12 MX MX2010012019A patent/MX2010012019A/es active IP Right Grant
- 2009-05-12 AU AU2009247021A patent/AU2009247021B2/en not_active Ceased
- 2009-05-12 CN CN2012104520326A patent/CN102908624A/zh active Pending
- 2009-05-12 RU RU2010147881/15A patent/RU2010147881A/ru not_active Application Discontinuation
- 2009-05-12 US US12/992,226 patent/US20110190309A1/en not_active Abandoned
- 2009-05-12 EP EP09746868.0A patent/EP2315589A4/en not_active Withdrawn
- 2009-05-12 CA CA2723909A patent/CA2723909A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI343809B (en) | A pharmaceutical composition for inhibiting coronavirus | |
| US9980927B2 (en) | Use of tapentadol for inhibiting and/or treating depression and anxiety | |
| FI3504187T3 (fi) | Pridopidiinin käyttö toiminnallisen heikkenemisen hoitoa varten | |
| KR20200016889A (ko) | 과다 졸림증을 치료하기 위한 방법 및 조성물 | |
| JP2018513107A5 (https=) | ||
| JP2013516488A (ja) | 炭酸脱水酵素阻害薬およびさらなる活性剤の組み合わせによる閉塞型睡眠時無呼吸症候群の治療 | |
| JP2009537565A (ja) | Ｒ（＋）およびｓ（−）プラミペキソール組成とそれを利用する方法 | |
| JP2018509438A (ja) | 呼吸器疾患の治療 | |
| JP2011520877A5 (https=) | ||
| US20180271840A1 (en) | Compositions and methods for treating amyotrophic lateral sclerosis in responders | |
| CN115227825A (zh) | Rxr激动剂和甲状腺激素在制备用于治疗自身免疫疾病的药物中的用途 | |
| JP2003176240A (ja) | ニコチン性アセチルコリン受容体作用薬により関節の潤滑を高める方法 | |
| JP2015522077A5 (https=) | ||
| JP2014511897A5 (https=) | ||
| JP2009242366A (ja) | 持続性解熱鎮痛消炎剤 | |
| JP2013536206A5 (https=) | ||
| JP2008115167A (ja) | トラネキサム酸を含有する気道杯細胞過形成抑制剤 | |
| JP7369523B2 (ja) | 中等度～重度のインフルエンザの処置 | |
| WO2019089523A1 (en) | Hydrophobic acid addition salts and pharmaceutical formulations thereof | |
| RU2011105463A (ru) | ФАРМАЦЕВТИЧЕСКИЙ ПРОДУКТ, СОДЕРЖАЩИЙ АНТАГОНИСТ МУСКАРИНОВОГО РЕЦЕПТОРА И АГОНИСТ β2-АДРЕНОРЕЦЕПТОРА | |
| JP2021503448A5 (https=) | ||
| CA3177652A1 (en) | Methods of treating pulmonary fibrosis | |
| JP2007509946A5 (https=) | ||
| JP2010523662A (ja) | 睡眠関連呼吸障害を処置するための方法及び組成物 | |
| JP6594899B2 (ja) | 特発性肺線維症の治療方法 |